Abstract
Objective
To explore the effects and anti-depression mechanisms of Kaixin Jieyu Decoction (开心解郁汤, KJD).
Methods
The rat vascular depression (VD) model was established by ligation of bilateral common carotid arteries (LBCCA) combined with chronic unpredictable mild stress (CUMS). Forty Wistar rats were randomly divided into sham, VD model, VD + high-dose KJD [15.4 g/(kg·d) of crude drug], VD + medium-dose KJD [7.7 g/(kg·d) of crude drug], and VD + fluoxetine [2.4 mg/(kg·d)] groups (n=8 in each group), and the treatments lasted for 21 days. Changes of behavior and hippocampus pathology were observed. The level of glial fibrillary acidic protein (GFAP) protein and mRNA in hippocampus was detected respectively by immunohistochemistry and real-time polymerase chain reaction.
Results
Compared with the sham group, rats in model group showed a variety of behavioral obstacles, including a significant reduction in sucrose consumption percentage, horizontal and vertical activity scores in open-field tests (P<0.05 or P<0.01), pathological damage like neuronal degeneration, necrosis, and a significant decrease of GFAP protein and mRNA in hippocampus (P<0.01); compared with the model group, rats in the high-dose KJD group, medium-dose KJD group and fluoxetine group obtained notable higher behavioral scores, and pathological injury lessened in hippocampus with a increased expression of GFAP protein and mRNA P<0.05 or P<0.01); compared with the medium-dose KJD group and fluoxetine group, GFAP mRNA in high-dose KJD group expressed higer (P<0.05).
Conclusion
LBCCA combined with CUMS may cause depression-like behavioral changes resulting in the VD model of rats whose depression state can be ameliorated by KJD, and the mechanism of cerebral protection is related possibly with promoting expression of GFAP in hippocampus.
Similar content being viewed by others
References
Huang SJ, Chen YX, Zhang XH. Vascular depression. Intern J Cerebrovascul Dis (Chin) 2010;18:522–526.
Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, McKinstry RC, MacFall JR, et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 2010;67:277–285.
Janssen J, Hulshoff Pol HE, de Leeuw FE, Schnack HG, Lampe IK, Kok RM, et al. Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression. J Neurol Neurosurg Psychiatry 2007;78:638–640.
Berton O, Nestle EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006;7:137–151.
Huang SJ, Zhang XH, Wang YY, Pang JH, Cui HM, Fang SP, et al. Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model. Chin J Integr Med 2014; 2014;20:280–285.
National Research Council Guide for the Care and Use of Laboratory Animals. 7th ed. Washington, D.C.: Public Health Service; 1996.
Willner P. Validity, reliability and utility of the chronic mild stress model of depression a 10-year review and evaluation. Psychopharmacology (Berl) 1997;134:319–329.
Wang SS, Yan XB, Hofman MA, Swaab DF, Zhou JN. Increased expression level of corticotropin-releasing hormone in the amygdala and in the hypothalamus in rats exposed to chronic unpredictable mild stress. Neurosci Bull 2010;26:297–303.
Lin YH, Liu AH, Xu Y, Tie L, Yu HM, Li XJ. Effect of chronic unpredictable mild stress on brain-pancreas: relative protein in rat brain and pancreas. Behav Brain Res 2005;165:63–71.
Zhang XH, Huang SJ. Research progress in Chinese medicine of vascular depression. Liaoning J Tradit Chin Med (Chin) 2011;38:1012–1014.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. J Lancet 2006;367:1747–1757.
Wang SH, Zhang ZJ, Guo YJ, Zhou H, Teng GJ, Chen BA, et al. Anhedonia and activity deficits in rats: impact of poststroke depression. J Psychopharmacol 2009;23:295–304.
Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008;358:55–68.
Zhang JJ. Advances in astrocytes. Chin Pharmacol Bull 2006;22:788–791.
He F, Sun YE. Glial cells more than support cell. Int J Biochem Cell Biol 2007;39:661–665.
Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003;23:137–149.
Chu X, Fu X, Zou L, Qi C, Li Z, Rao Y, et al. Oncosis, the possible cell death pathway in astrocytes after focal cerebral ischemia. Brain Res 2007;1149:157–164.
Si X, Miguel-Hidalgo JJ, O’Dwyer G, Stockmeier CA, Rajkowska G. Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 2004;29:2088–2096.
Webster MJ, O’Grady J, Kleinman JE, Weickert CS. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 2005;133:453–461.
Leventopoulos M, Rüedi-Bettschen D, Knuesel I, Feldon J, Pryce CR, Opacka-Juffry J. Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Res 2007;1142:119–126.
Czéh B, Simon M, Schmelting B, Hiemke C, Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 2006;31:1616–1626.
Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL, et al. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamatemodulating drug riluzole. Mol Psychiatry 2010;15:501–511.
Chen HX, Zhang LM, Zhang YZ, Zhao N, Li J, Li YF. Effect of agmatine on the neurons and astrocytes in hippocampus of chronically stressed rats. Chin Pharmacol Bull 2009;25:21–25.
Gosselin RD, Gibney S, O’Malley D, Dinan TG, Cryan JF. Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 2009;159:915–925.
Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC. Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression. Eur Neuropsychopharmacol 2009;19:796–805.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China (No. 81072801 and 30672696)
Rights and permissions
About this article
Cite this article
Zhang, Xh., Huang, Sj., Wang, Yy. et al. Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior and glial fibrillary acidic protein expression in cerebral hippocampus of a rat vascular depression model. Chin. J. Integr. Med. 21, 223–228 (2015). https://doi.org/10.1007/s11655-014-1820-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-014-1820-8